Advertisement

Topics

PeraHealth Inc. Company Profile

12:19 EST 14th November 2018 | BioPortfolio

PeraHealth has spent 10 years building and validating the Rothman Index: a completely new model for predicting patient risk and visualizing patient condition across the continuum of care. Serving as the scientific engine of PeraTrend, the Index is protected by five patents and is squarely rooted in clinical and scientific rigor, with 10 peer-reviewed published journal articles validating its core methodology. The firm’s vision: constantly strive to increase patient safety, transform the EHR into a true clinical decision support tool and support the continuum of care in a seamless fashion – all while continuing to expand the firm’s scientific and clinical impact.


News Articles [4 Associated News Articles listed on BioPortfolio]

FDA clears PeraHealth's lifesaving clinical surveillance tech

Groundbreaking technology from PeraHealth that monitors patient health and flags up anomalies has been given the green light by the Food and Drug Administration (FDA). PeraTrend is the first solution...

PeraHealth Receives U.S. FDA 510(k) Clearance for Industry-Leading Clinical Surveillance Technology

Rothman Index-powered technology trusted by leading healthcare organizations nationwide PeraHealth today announced that its predictive, real-time clinical surveillance ...

PeraHealth Appoints Greg White as Chief Executive Officer

Senior healthcare IT executive selected to lead clinical surveillance company’s next phase of growth PeraHealth, a provider of predictive, real-time clinical surveill...

PeraHealth Launches Rothman Society for Innovation and Research

Membership opens for rigorous scientific discussion on how data can improve key patient care areas PeraHealth, an innovative provider of predictive, real-time clinical ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

PeraHealth, Inc.

PeraHealth has spent ten years building and validating the Rothman Index: a completely new model for predicting patient risk and visualizing patient condition across the continuum...

PeraHealth Inc.

PeraHealth has spent 10 years building and validating the Rothman Index: a completely new model for predicting patient risk and visualizing patient condition across the continuum ...

More Information about "PeraHealth Inc." on BioPortfolio

We have published hundreds of PeraHealth Inc. news stories on BioPortfolio along with dozens of PeraHealth Inc. Clinical Trials and PubMed Articles about PeraHealth Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PeraHealth Inc. Companies in our database. You can also find out about relevant PeraHealth Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record